Testosterone Overprescribing Poses Infertility Risks, Urologists Warn

Men receiving unnecessary testosterone therapy face risks of infertility, hormonal complications, and other adverse health effects from inadequately monitored treatments.
Months of therapy may have already done the damage
Infertility from testosterone treatment can be long-lasting or permanent, often discovered only when men try to have children.

Across social media and telehealth platforms, testosterone replacement therapy has become a marketplace commodity, prescribed to men who may not need it and monitored by no one who might notice the harm. Urologists are raising a measured but urgent warning: when medicine is reduced to a transaction, the body keeps the ledger. The consequences — infertility, blood disorders, hormonal disruption — are not hypothetical, and for some men, they are already irreversible.

  • Online clinics and wellness platforms are prescribing testosterone with minimal screening, bypassing the clinical standards that exist precisely to protect patients from unnecessary harm.
  • The most alarming risk is infertility — testosterone suppresses the body's own sperm production, and men who want children may not discover the damage until it is too late to undo.
  • Beyond fertility, the complications compound: dangerous increases in red blood cell density, worsened sleep apnea, mood instability, and potential liver damage from inadequately monitored treatment.
  • Major urology and endocrinology bodies have published clear prescribing standards, but many commercial providers compress or skip these steps entirely to keep patients cycling through refills.
  • Health systems are now actively working to pull testosterone prescribing back into evidence-based practice — urging men to seek evaluation from specialists trained to ask whether the treatment is actually warranted.

Testosterone replacement therapy has become a booming industry, carried on the current of social media promises and telehealth convenience. But urologists are sounding a clear alarm: the hormone is being handed to men who don't need it, often without the medical evaluation that clinical guidelines require, and the damage can be severe and lasting.

Testosterone therapy does have legitimate uses — for men with clinically documented low levels caused by specific conditions, it can be appropriate and beneficial. But the prescribing landscape has drifted far from that narrow indication. Online clinics are issuing prescriptions based on cursory questionnaires and decontextualized blood tests, making it easy for men seeking more energy, better sexual function, or muscle gain to obtain the hormone without ever consulting a specialist who might ask harder questions.

The most troubling consequence is infertility. When men take testosterone, the pituitary gland stops signaling the testes to produce their own hormone and sperm. A man may not discover the damage until he and a partner try to conceive — by which point months or years of therapy may have already taken their toll. The harm can be permanent.

Other risks are equally documented: dangerously elevated red blood cell counts, increased clotting risk, worsened sleep apnea, mood disruption, and liver complications. These emerge precisely when testosterone is given without proper justification and without the ongoing monitoring that responsible prescribing demands.

Health systems including UVA and WVU Medicine are working to restore rigor to this space, urging patients to seek evaluation from urologists or endocrinologists who will determine whether low testosterone is genuinely present, whether it is causing symptoms, and whether treatment is warranted. For men already on testosterone obtained through less careful channels, the guidance is direct: seek a proper evaluation now, before a pursuit of quick vitality becomes a permanent cost.

Testosterone replacement therapy has become a booming business, promoted across social media and telehealth platforms with promises of restored vigor and vitality. But urologists are sounding an alarm: the hormone is being prescribed to men who don't need it, often without the basic medical evaluation that guidelines require, and the consequences can be severe and sometimes irreversible.

The problem is straightforward in principle but widespread in practice. Testosterone therapy does have legitimate uses—for men with clinically low testosterone levels caused by specific medical conditions, the treatment can be appropriate and beneficial. But the current landscape of prescribing has drifted far from that narrow indication. Online clinics and wellness centers are handing out prescriptions based on minimal screening, sometimes just a questionnaire and a blood test ordered without proper context. Men seeking to boost energy, improve sexual function, or build muscle are finding it easy to obtain the hormone without ever seeing a urologist or endocrinologist who might ask harder questions about whether they actually need it.

The medical community's concern centers on a particular and troubling consequence: infertility. When men take testosterone, especially at the doses often prescribed, the body's natural feedback system shuts down. The pituitary gland stops signaling the testes to produce their own testosterone and sperm. For men who want to father children—or might want to in the future—this can mean permanent or long-lasting damage to fertility. A man might not realize the risk until he and a partner try to conceive and discover his sperm count has plummeted. By then, months or years of therapy may have already done the damage.

Beyond infertility, the risks extend to other hormonal complications. Testosterone therapy can increase red blood cell production to dangerous levels, thicken the blood, and raise the risk of clots. It can worsen sleep apnea, trigger or worsen acne, and cause mood swings or aggression. Some men develop liver problems. These are not theoretical risks—they are documented complications that emerge when testosterone is given without proper medical justification and without the ongoing monitoring that responsible prescribing demands.

The gap between guideline-based practice and what's actually happening in the market is substantial. Major medical organizations, including urology societies, have published clear standards for who should receive testosterone therapy and how it should be monitored. Those standards call for documented low testosterone levels, symptoms consistent with deficiency, exclusion of other causes, and regular follow-up with blood work and clinical assessment. But many online providers skip these steps or compress them into a cursory process designed to move patients through quickly and keep them paying for refills.

Health systems like UVA and WVU Medicine are now working to educate patients and providers about the risks and to establish safer, more rigorous approaches to testosterone therapy. Their message is direct: if you're considering testosterone treatment, get evaluated by a urologist or endocrinologist who will take time to determine whether you actually have low testosterone, whether it's causing your symptoms, and whether the benefits outweigh the risks in your particular situation. If you do start therapy, expect regular monitoring and a clear plan for how long you'll stay on it.

For men already on testosterone obtained through less rigorous channels, the advice is to seek a proper medical evaluation. Some may need to stop the therapy and allow their natural testosterone production to recover—a process that can take months. Others may find that their symptoms improve without the hormone once other causes are addressed. The key is bringing these treatments back under the oversight of doctors trained to prescribe them responsibly, before more men face the difficult discovery that pursuing a quick fix has cost them their fertility.

Urologists warn that testosterone therapy without proper medical justification carries risks including infertility and other complications
— Medical experts and urologists
The Hearth Conversation Another angle on the story
Inventor

Why is testosterone being prescribed so much more now than it was ten or twenty years ago?

Model

A lot of it is marketing. The internet made it easy for clinics to reach men directly with messages about low energy, weak libido, poor muscle tone—things that testosterone might help with, but might also be caused by sleep problems, depression, or just getting older. When you can order a test online and get a prescription without leaving your house, the barrier to treatment disappears.

Inventor

But testosterone does work for some people, right? It's not like it's a placebo.

Model

Absolutely. For men with genuinely low testosterone from a medical condition, it can be transformative. The problem is figuring out who actually has that condition versus who just feels tired or wants to be stronger. That requires real evaluation—blood tests done at the right time of day, symptoms that match the diagnosis, ruling out other causes. Most online clinics skip that.

Inventor

And the infertility thing—is that permanent?

Model

It can be. When you take testosterone, your body stops making its own. That includes the signals that tell your testes to produce sperm. Some men recover fertility after stopping, but it can take a long time, and some don't recover fully. If you're a young man who might want kids someday, that's a serious gamble to take without understanding the risk.

Inventor

So what should someone do if they think they have low testosterone?

Model

See a urologist or endocrinologist. Not a telehealth clinic, not a wellness center. Someone trained to diagnose the condition properly and monitor you if you start treatment. It takes more time, but it protects you from unnecessary therapy and from complications you might not see coming.

Inventor

Is this a problem that's getting better or worse?

Model

Right now it's getting worse because the market for testosterone keeps growing. But there's pushback from medical institutions trying to establish better standards and educate patients about the real risks. It's a slow process, though, because the financial incentives all point toward more prescriptions, not fewer.

Contact Us FAQ